Key takeaway
Among 13 018 non-exercising women in the UK Biobank, a median 3.4 minutes a day of vigorous intermittent lifestyle activity (VILPA) was linked to fewer major cardiovascular events (HR 0.55, 95% CI 0.41-0.75) than none. Men's 9350-person curves were unclear, and this observational link may partly reflect who is naturally active.
Study design
Research article
Reading basis
Published abstract
Reading focus
Design & applicability
The research question
Brief bursts of intense effort built into daily life, such as hurrying up stairs, may offer a route to health for people who do not exercise. The authors tested whether the dose-response link between daily VILPA and major adverse cardiovascular events, including heart attack, heart failure and stroke, differs between women and men.
Who and how
Prospective analysis of UK Biobank participants wearing accelerometers, restricted to non-exercisers (self-reported no leisure-time exercise and no more than one recreational walk a week): 13 018 women and 9350 men, followed for 7.9 years. Multivariable-adjusted cubic splines related daily VILPA duration to overall MACE and to incident myocardial infarction, heart failure and stroke. Analogous analyses of vigorous activity were run in exercisers from the accelerometry sub-study.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Women had 331 MACE events and men 488. In women, more daily VILPA showed a near-linear association with lower risk of all MACE, myocardial infarction and heart failure; in men the curves were less clear, with less statistical evidence.
- 2Compared with women with no VILPA, women's median of 3.4 minutes a day was associated with an HR of 0.55 (0.41-0.75) for all MACE and 0.33 (0.18-0.59) for heart failure.
- 3Women's minimum doses of 1.2-1.6 minutes a day were associated with HRs of 0.70 (0.58-0.86) for all MACE, 0.67 (0.50-0.91) for myocardial infarction and 0.60 (0.45-0.81) for heart failure.
- 4Among exercisers, there were no appreciable sex differences in the dose-response.
Limits & uncertainty
- 1This is observational: healthier or more capable women may do more VILPA, and the abstract does not rule out residual confounding or reverse causation.
- 2Activity was captured by wrist accelerometer over a limited period and projected to a 7.9-year follow-up, so habits may have changed.
- 3Event counts were modest (331 in women, 488 in men), and the men's less clear curves may reflect fewer events rather than a true absence of benefit.
- 4This reading is based on the abstract only.
What to take from it
Even a few minutes of hard effort scattered through the day, such as brisk stair climbing or a fast walk uphill, was associated with fewer cardiovascular events in women who do not exercise. That is an association, not proof, and it does not mean men gain nothing. If you have heart disease or symptoms, ask your clinician what level of intensity is safe.
Reading your own data
Many watches estimate minutes of vigorous activity or high heart-rate zones, and these can approximate VILPA. Compare your own weekly average on the same device with the same heart-rate settings, because wrist devices differ in how they classify short bursts.
How to read this evidence
The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Background
Vigorous intermittent lifestyle physical activity (VILPA) refers to brief bouts of intense physical activity embedded into daily life.
Objective
To examine sex differences in the dose-response association of VILPA with major adverse cardiovascular events (MACE) and its subtypes.
Methods
Using multivariable-adjusted cubic splines, we examined the associations of daily VILPA duration with overall MACE and its subtypes (incident myocardial infarction, heart failure and stroke) among non-exercisers (individuals self-reporting no leisure-time exercise and no more than one recreational walk per week) in the UK Biobank. We also undertook analogous analyses for vigorous physical activity among exercisers (individuals self-reporting participation in leisure-time exercise and/or recreational walking more than once a week).
Results
Among 13 018 women and 9350 men, there were 331 and 488 all MACE, respectively, over a 7.9-year follow-up. In women, daily VILPA duration exhibited a near-linear dose-response association with all MACE, myocardial infarction and heart failure. In men, dose-reponse curves were less clear with less evidence of statistical signifigance. Compared with women with no VILPA, women's median daily VILPA duration of 3.4 min was associated with hazard ratios (HRs; 95% confidence intervals) of 0.55 (0.41 to 0.75) for all MACE and 0.33 (0.18 to 0.59) for heart failure. Women's minimum doses of 1.2-1.6 min of VILPA per day were associated with HRs of 0.70 (0.58 to 0.86) for all MACE, 0.67 (0.50 to 0.91) for myocardial infarction, and 0.60 (0.45 to 0.81) for heart failure. The equivalent analyses in UK Biobank's accelerometry sub-study exercisers suggested no appreciable sex differences in dose-response.
Conclusions
Among non-exercising women, small amounts of VILPA were associated with a substantially lower risk of all MACE, myocardial infarction and heart failure. VILPA may be a promising physical activity target for cardiovascular disease prevention, particularly in women unable or not willing to engage in formal exercise.
Sources & attribution
Device-measured vigorous intermittent lifestyle physical activity (VILPA) and major adverse cardiovascular events: evidence of sex differences.
Stamatakis E, Ahmadi M, Biswas RK, Del Pozo Cruz B, Thøgersen-Ntoumani C, Murphy MH, Sabag A, Lear S, Chow C, Gill JMR, Hamer M.
British journal of sports medicine · 2025-02-20
DOI: 10.1136/bjsports-2024-108484 ↗PubMed · 39467622 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
7,000 steps a day linked to lower risk of death, heart disease and dementia than 2,000
Compared with 2000 steps a day, 7000 steps was associated with a hazard ratio of 0.53 (95% CI 0.46 to 0.60) for all-cause mortality across 14 studies, 0.75 (0.67 to 0.85) for cardiovascular disease and 0.62 (0.53 to 0.73) for dementia; cancer incidence was not significantly different (0.94, 0.87 to 1.01). Several outcomes rest on only two to four studies, and the certainty of evidence ranged from moderate to very low.
The Lancet Public Health
Brief bursts of vigorous effort in daily life linked to lower mortality in non-exercisers
Among 25,241 UK Biobank adults who reported no leisure-time exercise, a median of 3 vigorous bouts of 1 or 2 minutes a day, picked up by a wrist accelerometer, was associated with a 38% to 40% lower risk of all-cause and cancer death and a 48% to 49% lower risk of cardiovascular death than no such bouts, over an average of 6.9 years and 852 deaths. This is an observational study using one week of wrist data and an algorithm to define vigorous effort, so it cannot show that adding such bursts causes the lower risk.
Nature Medicine
Steps and mortality: gains flatten near 6,000–8,000 (age 60+) and 8,000–10,000 (under 60)
Pooling 15 cohorts (47,471 adults, 3,013 deaths, median follow-up 7.1 years), the second, third and fourth quartiles of daily steps (medians 5,801, 7,842 and 10,901) had hazard ratios for death of 0.60, 0.55 and 0.47 against the lowest quartile (median 3,553). The curve flattened at about 6,000 to 8,000 steps a day for adults aged 60 and over and 8,000 to 10,000 for younger adults. The data are observational, from a single week of step counting, mostly with waist-worn research devices.
The Lancet Public Health
Accelerometers on 36,383 adults: any activity, even light, linked to lower mortality
In eight pooled cohorts (36,383 adults, mean age 62.6 years, 2,149 deaths over a median 5.8 years), the most active quarter by accelerometer-measured total activity had a mortality hazard ratio of 0.27 (95% CI 0.23 to 0.32) against the least active, and the most sedentary quarter had 2.63 (1.94 to 3.56). Light activity alone showed the same pattern, with 0.38 (0.28 to 0.51) in the top quarter. These are observational associations in adults aged 40 and over from the US and western Europe, so illness-driven inactivity and confounding cannot be excluded.
BMJ

